The UK has the bottom survival rates for 5 of seven key cancers amongst some of the world’s richest nations.
Although survival rates are bettering, the UK got here bottom of the desk for bowel, lung, pancreatic, abdomen and rectal cancer.
Cancer Research UK analysed 3.9 million cancer circumstances between 1995 and 2014 in seven comparable high-income international locations with common healthcare (Australia, Canada, Denmark, Ireland, New Zealand, Norway and the UK).
Only for oesophagus and ovary cancer did UK do higher than some of the opposite international locations.
The authors of the research mentioned the variations between the international locations was partly defined by how shortly sufferers get a analysis after which immediate entry to efficient therapy.
Cancer Research UK’s scientific adviser, John Butler, who co-authored the research and is a guide surgeon on the Royal Marsden Hospital in London, mentioned: “For lung, ovarian, and oesophageal cancer specifically, survival has elevated largely as a result of the standard of surgical procedure has radically improved, and extra surgical procedure is going down than earlier than.
“More persons are being taken care of by specialist groups, reasonably than surgeons who aren’t specialists in that space.
“But, whereas we’re nonetheless researching what may be carried out to shut the survival hole between international locations, we all know continued funding in early analysis and cancer care performs a giant half.
“Despite our modifications, we have made slower progress than others.”
However the analysis did present that cancer survival one 12 months after analysis and on the five-year mark has improved throughout all seven varieties of cancer within the UK over the past 20 years.
For instance, five-year survival for rectal cancer within the UK has risen by 14 share factors since 1995, from 48% to 62%.
The UK additionally has one of the very best will increase in five-year survival – nearly 12 share factors – throughout all international locations for bowel cancer.
Sara Hiom, Cancer Research UK’s director of early analysis, mentioned: “While we’re heading in the right direction, the numbers present we are able to actually do higher.
“We will not see the necessary improvements in diagnosis and access to treatment unless we have enough of the right staff across our NHS.”
Responding to the report, NHS England mentioned it was out of date, whereas the Department of Health and Social Care cited different information exhibiting one-year survival rates for all kinds of cancer are at a file excessive.
In England, one-year survival has elevated from 62% in 2001 to 72.8% in 2016.
A spokesman mentioned: “Cancer survival rates are at a file excessive, however we’re decided to go additional and save much more
“Through our NHS Long Term Plan, we are going to detect extra cancers at an earlier stage, saving an estimated 55,000 lives a 12 months.
“Alongside this, the record #33.9 billion extra a year we’re investing in our NHS will help support the health service in recruiting the staff it needs for the future.”